| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | EW Edwards Lifesciences Corp | Gallahue Kieran | Director | Sell | 3,058 | $87.61 | $267,911.38 | -4.4% | -0.3% | -16.5% | |
| Feb 23, 2024 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 6,983 | $66.89 | $467,092.87 | -11.0% | +11.0% | +56.0% | |
| Feb 23, 2024 | UFPT Ufp Technologies Inc | Bailly R Jeffrey55 | CEO | Sell | 27,090 | $209.48 | $5,674,681.95 | -32.4% | +17.3% | +20.9% | |
| Feb 23, 2024 | UFPT Ufp Technologies Inc | Litterio Christopher P. | Senior Vice President | Sell | 2,000 | $208.65 | $417,305.94 | -2.6% | +17.3% | +20.9% | |
| Feb 23, 2024 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 41,601 | $3.23 | $134,371.23 | -1.5% | -30.1% | +25.5% | |
| Feb 23, 2024 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 140,245 | $92.14 | $12,922,001.63 | -25.1% | +20.0% | +40.5% | |
| Feb 22, 2024 | BRKR Bruker Corp | Prause Burkhard | Pres. &CEO, Bruker Best | Sell | 15,319 | $83.30 | $1,276,072.70 | -47.3% | -6.5% | -39.3% | |
| Feb 22, 2024 | KIDS Orthopediatrics Corp | Hauser Joseph W60 | Pres. Trauma &Def. Correction | Sell | 2,903 | $28.06 | $81,458.18 | -5.2% | +17.0% | -16.2% | |
| Feb 22, 2024 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 1,184 | $14.20 | $16,812.80 | -0.5% | -24.5% | -24.5% | |
| Feb 22, 2024 | ZBH Zimmer Biomet Holdings, Inc. | Phipps Chad F53 | Sr. Vp/ Gen Counsel/ Secretary | Sell | 26,156 | $128.62 | $3,364,125.99 | -22.7% | -7.2% | -18.4% | |
| Feb 22, 2024 | RMD Resmed Inc | Farrell Peter C55 | Director | Sell | 23,535 | $211.85 | $4,985,808.88 | -6.8% | +19.2% | +26.5% | |
| Feb 21, 2024 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 17,820 | $15.34 | $273,358.80 | -2.6% | -30.5% | -30.6% | |
| Feb 21, 2024 | MDT Medtronic Plc | Salmon Sean52 | EVP &President Cardiovascular | Sell | 30,695 | $85.13 | $2,613,054.74 | -13.9% | -0.8% | +2.4% | |
| Feb 21, 2024 | ATEC Alphatec Holdings, Inc. | Lish Scott61 | Chief Operating Officer | Sell | 11,963 | $15.34 | $183,512.42 | -2.2% | -30.5% | -30.6% | |
| Feb 21, 2024 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 4,960 | $66.35 | $329,096.00 | -6.4% | +15.1% | +60.2% | |
| Feb 21, 2024 | BLFS Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | Sell | 131 | $17.35 | $2,272.85 | -0.2% | +23.9% | +57.2% | |
| Feb 21, 2024 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 111 | $17.35 | $1,925.85 | - | +23.9% | +57.2% | |
| Feb 21, 2024 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 97 | $17.35 | $1,682.95 | -0.1% | +23.9% | +57.2% | |
| Feb 21, 2024 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 58 | $17.35 | $1,006.30 | -0.1% | +23.9% | +57.2% | |
| Feb 21, 2024 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 101 | $17.35 | $1,752.35 | - | +23.9% | +57.2% | |
| Feb 21, 2024 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Tmtt | Sell | 8,200 | $86.74 | $711,271.74 | -13.5% | +4.3% | -13.8% | |
| Feb 21, 2024 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 87 | $17.35 | $1,509.45 | - | +23.9% | +57.2% | |
| Feb 20, 2024 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 22,625 | $0.36 | $8,242.29 | -1.8% | +9.0% | +49.1% | |
| Feb 20, 2024 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 10,000 | $0.34 | $3,400.00 | +11.6% | -26.1% | -95.1% | |
| Feb 20, 2024 | CVRX Cvrx, Inc. | Verrastro Paul63 | Chief Mktg &Strat Officer | Sell | 2,545 | $21.91 | $55,748.23 | -50.9% | -62.8% | -34.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.